These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 11660185

  • 1. Ethical aspects of pharmaceutically-based clinical investigation: report on a national workshop.
    Miller J, Kinsella D, Klein A, Rusted I.
    NCBHR Commun; 1990; 1(1):7-10. PubMed ID: 11660185
    [No Abstract] [Full Text] [Related]

  • 2. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D.
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract] [Full Text] [Related]

  • 3. The changing clinical trials scene: the role of the IRB.
    Mitchell SC, Steingrub J.
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract] [Full Text] [Related]

  • 4. IRBs and randomized clinical trials.
    Meinert CL.
    IRB; 1998; 20(2-3):9-12. PubMed ID: 11656915
    [No Abstract] [Full Text] [Related]

  • 5. Ethics of Research Involving Children: Proceedings of a National Workshop.
    National Council on Bioethics in Human Research (Canada).
    NCBHR Commun; 1993; 4(1):12-41. PubMed ID: 11659941
    [No Abstract] [Full Text] [Related]

  • 6. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM.
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract] [Full Text] [Related]

  • 7. Ethical issues in clinical neurological research.
    Shore D, Berg K, Mullican C.
    J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
    [No Abstract] [Full Text] [Related]

  • 8. Informed consent: the FDA's perspective.
    Bagley G.
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IRB review of adverse events in investigational drug studies.
    Prentice ED, Gordon B.
    IRB; 1997; 19(6):1-4. PubMed ID: 11656910
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ.
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Questions and answers.
    Goodwin FK.
    J Calif Alliance Ment Ill; 1994; 5(1):45-7. PubMed ID: 11653321
    [No Abstract] [Full Text] [Related]

  • 16. Proposal for a good clinical practice directive.
    European Commission.
    Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
    [No Abstract] [Full Text] [Related]

  • 17. The Ethics of Human Experimentation: Reinventing the Research Ethics Board: Proceedings of a National Workshop held in Ottawa, Ontario, March 5-6, 1995.
    National Council on Bioethics in Human Research (Canada).
    NCBHR Commun; 1996 Feb; 7(1):5-35. PubMed ID: 11654527
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury.
    Prentice ED, Antonson DL, Leibrock LG, Kelso TK, Sears TD.
    IRB; 1993 Feb; 15(5):1-7. PubMed ID: 11659703
    [No Abstract] [Full Text] [Related]

  • 20. Informed consent in psychiatric research.
    Roth LH, Appelbaum PS, Lidz CW, Benson P, Winslade WJ.
    Rutgers Law Rev; 1987 Feb; 39(2-3):425-41. PubMed ID: 11659013
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.